Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Effect of paroxetine and risperidone on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptor in the context of obsessive-compulsive disorder

2012/05/N/NZ7/00664

Keywords:

paroxetine risperidone obsessive-compulsive disorder heterodimerization

Descriptors:

  • NZ7_14:

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk

woj. małopolskie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Magdalena Anna Kolasa 

Number of co-investigators in the project: 3

Call: PRELUDIUM 3 - announced on 2012-03-15

Amount awarded: 99 710 PLN

Project start date (Y-m-d): 2013-02-05

Project end date (Y-m-d): 2016-02-04

Project duration:: 36 months (the same as in the proposal)

Project status: Project settled

Information in the final report

  • Publication in academic press/journals (2)
  • Articles in post-conference publications (4)
  1. Paroxetine and low-dose risperidone induce serotonin 5-HT1A and dopamine D2 receptor heteromerization in the mouse prefrontal cortex
    Authors:
    Magdalena Kolasa, Joanna Solich, Agata Faron-Górecka, Dariusz Żurawek, Paulina Pabian, Sylwia Łukasiewicz, Maciej Kuśmider, Kinga Szafran-Pilch, Marta Szlachta, Marta Dziedzicka-Wasylewska
    Status:
    Accepted for publication
  2. Paroxetine and low-dose risperidone induce serotonin 5-HT1A and dopamine D2 receptor heteromerization in the mouse prefrontal cortex
    Authors:
    Magdalena Kolasa, Joanna Solich, Agata Faron-Górecka, Dariusz Żurawek, Paulina Pabian, Sylwia Łukasiewicz, Maciej Kuśmider, Kinga Szafran-Pilch, Marta Szlachta, Marta Dziedzicka-Wasylewska
    Status:
    Accepted for publication
  1. Paroxetine and risperidone influence the level of heterodimers of dopamine D2 and serotonin 5-HT1A receptors in brain cortex neuronal cells
    Authors:
    Magdalena Kolasa, Kinga Szafran, Dariusz Żurawek, Agata Faron-Górecka, Joanna Solich, Paulina Pabian, Maciej Kuśmider, Marta Dziedzicka-Wasylewska
    Conference:
    Status:
    Accepted for publication
  2. Effect of combined paroxetine and low-dose risperidone treatment on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptors in mice brain cortex
    Authors:
    Kolasa M., Solich J., Faron-Górecka A, Żurawek D., Pabian P., Szafran K., Kuśmider M., Dziedzicka-Wasylewska M.
    Conference:
    Status:
    Accepted for publication
  3. Paroxetine and risperidone influence the level of heterodimers of dopamine D2 and serotonin 5-HT1A receptors in brain cortex neuronal cells
    Authors:
    Magdalena Kolasa, Kinga Szafran, Dariusz Żurawek, Agata Faron-Górecka, Joanna Solich, Paulina Pabian, Maciej Kuśmider, Marta Dziedzicka-Wasylewska
    Conference:
    Status:
    Accepted for publication
  4. Effect of combined paroxetine and low-dose risperidone treatment on the heterodimerization of dopamine D2 and serotonin 5-HT1A receptors in mice brain cortex
    Authors:
    Kolasa M., Solich J., Faron-Górecka A, Żurawek D., Pabian P., Szafran K., Kuśmider M., Dziedzicka-Wasylewska M.
    Conference:
    Status:
    Accepted for publication